NCT07411209

Brief Summary

This is a randomized study to evaluate the effectiveness and implementation of an intervention to decrease unnecessary urine testing for surgical patients (Less is More for Surgical Urine Testing) across six geographically diverse Veterans Affairs Medical Centers. The intervention will unfold over two years, in three phases: control, intervention, and sustainability.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for not_applicable

Timeline
49mo left

Started Dec 2026

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 3, 2026

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 13, 2026

Completed
11 months until next milestone

Study Start

First participant enrolled

December 31, 2026

Expected
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2028

2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2030

Last Updated

February 13, 2026

Status Verified

February 1, 2026

Enrollment Period

2 years

First QC Date

February 3, 2026

Last Update Submit

February 10, 2026

Conditions

Keywords

antibiotic stewardshipkicking cauti

Outcome Measures

Primary Outcomes (1)

  • Number of Urine Testing Performed

    Throughout the study period, the research team will generate monthly lists of all urinalyses and urine cultures performed within 30 days before and 30 days after included procedures. The study team will chart review theses cases and determine whether the urine test was done on an asymptomatic patient or whether the test was justified based on UTI symptoms.

    up to 48 months

Secondary Outcomes (2)

  • Number of Days of Therapy

    up to 48 months

  • Budget Impact Analysis

    up to 48 months

Study Arms (2)

Intervention Site Visit

EXPERIMENTAL

VAMCs randomized in this arm will receive full access to our resources library, will receive invites to our monthly meetings, receive monthly feedback on clinical outcomes, access to project materials, etc.

Behavioral: Interventional Project Site Visit

Standard of Care

NO INTERVENTION

VAMCs randomized to the standard arm will proceed with normal standard of care

Interventions

Activities occurring during the 12-month intervention phase * 1:1 meetings introducing the project * Site Visit (once during intervention period) * Interactive teaching cases and didactic sessions * Distribution of algorithm as pocket cards * Access to project materials on SharePoint * Feedback reports on clinical outcomes * Evidence-based order set templates * Learning collaborative webinars * Individualized coaching

Intervention Site Visit

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Medical Centers part of the Veterans Affairs Health Administration (VAMCs)
  • VAMCs that perform standard, intermediate, or advanced surgical procedures
  • VAMCs in which perioperative urine testing is performed among greater than 10% of their non-urologic, non-transplant surgery procedures

You may not qualify if:

  • VAMCs that only perform ambulatory surgery (outpatient/day surgery only)
  • VAMCs that do not perform urine testing among at least 10% of their non-urologic, non-transplant surgery procedures
  • VAMCs that already have implemented interventions to reduce perioperative urine testing
  • VAMCs' units performing genitourinary or transplant surgeries
  • Database of patients with a diagnosis of urinary tract infection within 30 days before surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

William S. Middleton Memorial Veterans Hospital, Madison, WI

Madison, Wisconsin, 53705-2254, United States

Location

MeSH Terms

Conditions

Urinary Tract Infections

Condition Hierarchy (Ancestors)

InfectionsUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Officials

  • Marin L. Schweizer-Looby, PhD BS

    William S. Middleton Memorial Veterans Hospital, Madison, WI

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Marin L Schweizer-Looby, PhD BS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
This study is a hybrid type 2 effectiveness/implementation study with a dual focus on clinical effectiveness and implementation outcomes using a stepped wedge cluster randomized trial among six recruited VAMCs.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SEQUENTIAL
Model Details: Stepped Wedge Cluster Randomized Trial
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 3, 2026

First Posted

February 13, 2026

Study Start (Estimated)

December 31, 2026

Primary Completion (Estimated)

December 31, 2028

Study Completion (Estimated)

December 31, 2030

Last Updated

February 13, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations